Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Healthy Extracts (HYEX) Return on Sales (2016 - 2025)

Healthy Extracts' Return on Sales history spans 11 years, with the latest figure at 0.16% for Q4 2025.

  • For Q4 2025, Return on Sales rose 9.0% year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.21%, down 15.0%, while the annual FY2025 figure was 0.21%, 15.0% down from the prior year.
  • Return on Sales reached 0.16% in Q4 2025 per HYEX's latest filing, up from 0.5% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.11% in Q3 2024 to a low of 3.44% in Q1 2021.
  • Average Return on Sales over 5 years is 0.65%, with a median of 0.34% recorded in 2023.
  • Peak YoY movement for Return on Sales: skyrocketed 1136bps in 2021, then tumbled -83bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.86% in 2021, then soared by 72bps to 0.24% in 2022, then crashed by -100bps to 0.48% in 2023, then soared by 48bps to 0.25% in 2024, then surged by 37bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Return on Sales are 0.16% (Q4 2025), 0.5% (Q3 2025), and 0.11% (Q2 2025).